These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 15818)

  • 1. Neuropsychological deficit in polydrug users. A preliminary report of the findings of the collaborative neuropsychological study of polydrug users.
    Grant I; Adams KM; Carlin AS; Rennick PM
    Drug Alcohol Depend; 1977 Mar; 2(2):91-108. PubMed ID: 15818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organic impairment in polydrug users: risk factors.
    Grant I; Adams KM; Carlin AS; Rennick PM; Judd LL; Schooff K; Reed R
    Am J Psychiatry; 1978 Feb; 135(2):178-84. PubMed ID: 623328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychological and EEG disturbances in polydrug users.
    Grant I; Judd LL
    Am J Psychiatry; 1976 Sep; 133(9):1039-42. PubMed ID: 961924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A neuropsychological study of polydrug users.
    Grant I; Mohns L; Miller M; Reitan RM
    Arch Gen Psychiatry; 1976 Aug; 33(8):973-8. PubMed ID: 949231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is phencyclidine (PCP) abuse associated with organic mental impairment?
    Carlin AS; Grant I; Adams KM; Reed R
    Am J Drug Alcohol Abuse; 1979; 6(3):273-81. PubMed ID: 539570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adult attention deficit hyperactivity disorder and other psychiatric symptoms in recreational polydrug users.
    Parrott AC; Hatton NP; Rowe KL; Watts LA; Donev R; Kissling C; Thome J
    Hum Psychopharmacol; 2012 Mar; 27(2):209-16. PubMed ID: 22389085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems.
    Parrott AC; Milani RM; Parmar R; Turner JD
    Psychopharmacology (Berl); 2001 Dec; 159(1):77-82. PubMed ID: 11797073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between maltreatment and polydrug use among adolescents.
    Alvarez-Alonso MJ; Jurado-Barba R; Martinez-Martin N; Espin-Jaime JC; Bolaños-Porrero C; Ordoñez-Franco A; Rodriguez-Lopez JA; Lora-Pablos D; de la Cruz-Bértolo J; Jimenez-Arriero MA; Manzanares J; Rubio G
    Child Abuse Negl; 2016 Jan; 51():379-89. PubMed ID: 26318780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.
    de Sola Llopis S; Miguelez-Pan M; Peña-Casanova J; Poudevida S; Farré M; Pacifici R; Böhm P; Abanades S; Verdejo García A; Langohr K; Zuccaro P; de la Torre R
    J Psychopharmacol; 2008 Jul; 22(5):498-510. PubMed ID: 18208910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrophysiological evidence of atypical processing underlying mental set shifting in ecstasy polydrug and polydrug users.
    Roberts CA; Fairclough SH; McGlone FP; Fisk JE; Montgomery C
    Exp Clin Psychopharmacol; 2013 Dec; 21(6):507-15. PubMed ID: 24080019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational polydrug use in psychiatry.
    Gerner R
    West J Med; 1991 Nov; 155(5):518. PubMed ID: 1687715
    [No Abstract]   [Full Text] [Related]  

  • 12. Problematic versus non-problematic ecstasy/MDMA use: the influence of drug usage patterns and pre-existing psychiatric factors.
    Soar K; Turner JJ; Parrott AC
    J Psychopharmacol; 2006 May; 20(3):417-24. PubMed ID: 16574716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polydrug Use and Heterogeneity in HIV Risk Among People Who Inject Drugs in Estonia and Russia: A Latent Class Analysis.
    Tavitian-Exley I; Boily MC; Heimer R; Uusküla A; Levina O; Maheu-Giroux M
    AIDS Behav; 2018 Apr; 22(4):1329-1340. PubMed ID: 28699018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of psychiatric illness in drug abusers. Possible role of drug preference.
    Mc Lellan AT; Woody GE; O'Brien CP
    N Engl J Med; 1979 Dec; 301(24):1310-4. PubMed ID: 41182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-reported psychopathology in polydrug users.
    Sumnall HR; Wagstaff GF; Cole JC
    J Psychopharmacol; 2004 Mar; 18(1):75-82. PubMed ID: 15107188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attributions for psychobiological changes in ecstasy/MDMA and other polydrug users.
    Soar K; Parrott A; Turner J
    J Psychopharmacol; 2009 Sep; 23(7):745-58. PubMed ID: 18635698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of high-frequency consumers of prescription psychoactive drugs.
    Chambers CD; White OZ
    Chem Depend; 1980; 4(1-2):33-46. PubMed ID: 6152789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methamphetamine-using HIV-positive men who have sex with men: correlates of polydrug use.
    Patterson TL; Semple SJ; Zians JK; Strathdee SA
    J Urban Health; 2005 Mar; 82(1 Suppl 1):i120-6. PubMed ID: 15738313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polydrug use and its association with drug treatment outcomes among primary heroin, methamphetamine, and cocaine users.
    Wang L; Min JE; Krebs E; Evans E; Huang D; Liu L; Hser YI; Nosyk B
    Int J Drug Policy; 2017 Nov; 49():32-40. PubMed ID: 28888099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analyses of use of tranquilizers and sleeping pills across five surveys of the same population (1985-1991): the relationship with gender, age and use of other substances.
    Graham K; Vidal-Zeballos D
    Soc Sci Med; 1998 Feb; 46(3):381-95. PubMed ID: 9460819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.